XML 59 R40.htm IDEA: XBRL DOCUMENT

SUPPLEMENTARY FINANCIAL STATEMENT INFORMATION (Tables)

12 Months Ended

Dec. 31, 2025

Disclosure of supplementary financial statement information [Abstract]

Schedule of Other Receivables

		December 31,
		2024				2025
		in USD thousands
Government institutions			455				33
Advance payments			91				-
Other			932				377
			1,478				410

Schedule of Accounts Payable and Accruals

		December 31,
		2024				2025
		in USD thousands
1) Trade:
Accounts payable:
Overseas			4,250				2,814
In Israel			1,333				679
			5,583				3,493
2) Other:
Payroll and related expenses			1,993				523
Accrued expenses			707				372
Accrual for vacation and recreation pay			431				310
Other			-				538
			3,131				1,743

Schedule of Cost of Revenues

		Year ended December 31,
		2023				2024				2025
		in USD thousands
License fees and royalties payable to licensor			3,027				3,024				230
Direct costs related to license revenues			203				2,605				-
Amortization of intangible asset			450				3,323				-
Cost of product sales			12				311				-
			3,692				9,263				230

Schedule of Research and Development Expenses

		Year ended December 31,
		2023				2024				2025
		in USD thousands
Research and development services			4,603				3,170				3,118
Payroll and related expenses			4,452				3,524				2,982
Lab, occupancy and telephone			969				1,102				855
Professional fees			935				273				390
Share-based compensation			760				451				104
Depreciation and amortization			583				431				495
Other			217				198				149
			12,519				9,149				8,093

Schedule of Sales and Marketing Expenses

		Year ended December 31,
		2023				2024				2025
		in USD thousands
Payroll and related expenses			8,868				12,224				-
Medical Affairs			4,824				2,891				-
Marketing			4,091				2,041				-
Travel			986				1,506				-
Office-related expenses			1,923				1,477				-
Business Analytics			1,005				1,264				-
Market Access			1,606				701				-
Professional fees			745				627				-
Share-based compensation			751				98				-
Depreciation and amortization			314				330				-
Loss on abandonment of right-of-use asset			-				246				-
Other			157				200				-
			25,270				23,605				-

Schedule of General and Administrative Expenses

		Year ended December 31,
		2023				2024				2025
		in USD thousands
Payroll and related expenses			2,117				2,000				1,407
Professional fees			2,028				1,991				1,290
Insurance			939				808				603
Share-based compensation			780				585				292
Depreciation			37				10				28
Provision for doubtful accounts receivable			-				800				(800	)
Other			409				127				324
			6,310				6,321				3,144

Schedule of Non-Operating Income (Expenses), Net

		Year ended December 31,
		2023				2024				2025
		in USD thousands
Changes in fair value of warrants			(11,054	)			18,965				8,599
Issuance costs			-				(669	)			(702	)
Other			235				139				180
			(10,819	)			18,435				8,077

Schedule of Financial Income

		Year ended December 31,
		2023				2024				2025
		in USD thousands
Interest income			2,007				1,820				1,124
Exchange differences, net			61				51				340
			2,068				1,871				1,464

Schedule of Financial Expenses

		Year ended December 31,
		2023				2024				2025
		in USD thousands
Interest expense			2,144				9,074				1,251
Bank commissions			25				45				29
			2,169				9,119				1,280